The Role of CELMoD Agents in Multiple Myeloma.
Saved in:
| Title: | The Role of CELMoD Agents in Multiple Myeloma. |
|---|---|
| Authors: | van de Donk NWCJ; Department of Hematology, Cancer Center Amsterdam, Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam, Netherlands., Bahlis NJ; Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, AB, Canada., Pawlyn C; The Institute of Cancer Research, London, UK.; The Royal Marsden NHS Foundation Trust, London, UK., Gay F; Department of Molecular Biotechnology and Health Science, Division of Hematology, University of Torino, AOU Città della Salute e della Scienza di Torino, Turin, Italy., Mateos MV; University Hospital of Salamanca/IBSAL, Salamanca, Spain., Weisel K; University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Lonial S; Winship Cancer Institute, Emory University, Atlanta, GA, USA., Richardson PG; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. |
| Source: | OncoTargets and therapy [Onco Targets Ther] 2025 Aug 27; Vol. 18, pp. 921-933. Date of Electronic Publication: 2025 Aug 27 (Print Publication: 2025). |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Dove Medical Press Country of Publication: New Zealand NLM ID: 101514322 Publication Model: eCollection Cited Medium: Print ISSN: 1178-6930 (Print) Linking ISSN: 11786930 NLM ISO Abbreviation: Onco Targets Ther Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
